Amantadine-Induced Corneal Edema in a Pediatric Neuro-Oncology Patient: A Case Report
Publication date: October 2018Source: PM&R, Volume 10, Issue 10Author(s): Maria Beran, Britta Okyere, Joshua VovaAbstractAmantadine is commonly prescribed as a neurostimulant in patients with brain injuries. This is a case of a 14-year-old male with a history of brain tumor that developed corneal edema after initiation of amantadine, a rare but documented side effect of this medication. After discontinuation of amantadine, the corneal edema resolved within two months, but endothelial cells density remained low.Level of EvidenceV
Source: PMandR - Category: Rehabilitation Source Type: research
More News: Amantadine | Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Neurology | Pediatrics | Symmetrel